Derek Dubay to Time Factors
This is a "connection" page, showing publications Derek Dubay has written about Time Factors.
Connection Strength
0.660
-
A Video Intervention to Increase Organ Donor Registration at the Department of Motorized Vehicles. Transplantation. 2020 04; 104(4):788-794.
Score: 0.096
-
Development and future deployment of a 5 years allograft survival model for kidney transplantation. Nephrology (Carlton). 2019 Aug; 24(8):855-862.
Score: 0.090
-
The impact of time-varying clinical surrogates on disparities in African-American kidney transplant recipients - a retrospective longitudinal cohort study. Transpl Int. 2019 01; 32(1):84-94.
Score: 0.086
-
A SEER Database Analysis of the Survival Advantage of Transarterial Chemoembolization for Hepatocellular Carcinoma: An Underutilized Therapy. J Vasc Interv Radiol. 2017 Feb; 28(2):231-237.e2.
Score: 0.076
-
Predictors of repeat transarterial chemoembolization in the treatment of hepatocellular carcinoma. HPB (Oxford). 2014 Dec; 16(12):1095-101.
Score: 0.065
-
Chemoembolization outcomes for hepatocellular carcinoma in cirrhotic patients with compromised liver function. HPB (Oxford). 2014 Jul; 16(7):648-55.
Score: 0.064
-
Equivalent survival following liver transplantation in patients with non-alcoholic steatohepatitis compared with patients with other liver diseases. HPB (Oxford). 2012 Sep; 14(9):625-34.
Score: 0.056
-
Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens. Liver Transpl. 2008 May; 14(5):651-9.
Score: 0.042
-
Intracerebroventricular calcitonin prevents stress-induced gastric dysfunction. J Surg Res. 2003 Mar; 110(1):188-92.
Score: 0.029
-
Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation. Transplantation. 2017 12; 101(12):2931-2938.
Score: 0.020
-
Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinoma. HPB (Oxford). 2016 10; 18(10):843-850.
Score: 0.019
-
Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients. Transplantation. 2016 Jan; 100(1):141-6.
Score: 0.018